Sunday 11 October 2026 Export all INNV data to Excel Powerpack

InnovAge Holding Corp.

INNV Healthcare Medical Care Facilities

InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025. In the quarter to June 2026, revenue grew 18.3%, EPS grew 700.0%, free cash flow grew 85.4% and total debt fell 16.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

9.10 0.01 −0.11%
Market cap
$1.2B
P/E
0.0×
Fwd P/E
17.2×
Dividend yield
—
F-score
6/9
Altman Z
4.58
Beneish M
−3.10
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

6 9 6 6
ROE
(6.69%) 2.50% (4.85%) (1.06%)
ROA
(3.35%) 1.23% (2.14%) (0.47%)
ROIC
(5.03%) 2.90% (3.84%) 1.06%
Return on Tangible Assets
(9.16%) 3.21% (6.75%) (1.44%)
Average Days of Receivables
10.93 9.81 12.29 16.84
Free Cash Flow per Share
0.27 0.37 0.34 0.40
Free Cash Flow
36.17 49.75 46.28 54.12
Capital Expenditures
(8.14) (9.16) (6.15) (10.59)
Other line items
Cash ROIC
8.52% 11.03% 10.64% 12.40%
Accounts Receivable Turnover
23.12 23.56 23.82 23.19
Accounts Payable Turnover
14.78 12.80 8.22 7.93
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
25.96 27.98 51.89 55.26
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.06 (0.35) 0.14 (3.57)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
17.42% 16.72% 20.31% 20.29%
Share Based Compensation of Revenue
0.88% 0.78% 0.72% 0.71%
Interest Coverage
(3.59) 1.81 (1.96) 0.61
Operating CF/Net income
(2.55) 9.10 (4.52) (25.51)
Depreciation/Fixed assets
0.12 0.12 0.11 0.13
Capex/Depreciation
(0.41) (0.47) (0.33) (0.48)
Revenue per Share
6.52 6.75 6.99 7.29
Operating CF per Share
0.33 0.43 0.39 0.48
Capex per Share
(0.06) (0.07) (0.05) (0.08)
Capex to Sales
0.01 0.01 0.01 0.01

Fold the line items

Columns are period end dates